Criteria for the use of omics-based predictors in clinical trials

The US National Cancer Institute (NCI), in collaboration with scientists representing multiple areas of expertise relevant to ‘omics’-based test development, has developed a checklist of criteria that can be used to determine the readiness of omics-based tests for guiding patient care in clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: McShane, Lisa M., Cavenagh, Margaret M., Lively, Tracy G., Eberhard, David A., Bigbee, William L., Williams, P. Mickey, Mesirov, Jill P., Polley, Mei-Yin C., Kim, Kelly Y., Tricoli, James V., Taylor, Jeremy M. G., Shuman, Deborah J., Simon, Richard M., Doroshow, James H., Conley, Barbara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180668/
https://www.ncbi.nlm.nih.gov/pubmed/24132288
http://dx.doi.org/10.1038/nature12564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180668/
https://www.ncbi.nlm.nih.gov/pubmed/24132288
http://dx.doi.org/10.1038/nature12564

Ejemplares similares